центр онкологии москва

Results of one of the most representative on number of participants (9366 patients with an operable cancer dairy железы in менопаузе) researches АТАС in which comparison of efficiency тамоксифена (20 mg / day is lead{carried out}), анастрозола (1 mg / day) and are submitted to their combination at адъювантном application within 5 years. Подробнее...

Braverman with соавт. (5) have estimated a hormonal background at 16 women (middle age 43 years) with come{stepped} owing to chemotherapy аменореей in from 3 till 44 months (a median - 8,5 months). The level сывороточного эстрадиола at 60 % of patients corresponded{met} пременопаузальному in spite of the fact that the level фолликулостимулирующего hormone (ФСГ) was in постменопаузальном a range. The received data are necessary for considering at purpose{assignment} ингибиторов ароматазы to women with induced chemotherapy аменореей. It is obvious, that at this category of patients менопаузальный it is necessary to confirm the status definition of a level эстрадиола and ФСГ which further should be supervised each 3 months. Подробнее...